Abstract
Seasonal day length has been linked to the prevalence of mood disorders, and however, the mechanisms underlying this relationship remain unknown. Previous work in our laboratory has shown that developmental exposure to seasonal photoperiods has enduring effects on the activity of mouse dorsal raphe serotonergic neurons, their intrinsic electrical properties, as well as on depression and anxiety-related behaviors. Here we focus on the possible ionic mechanisms that underlie the observed programming of the electrophysiological properties of serotonin neurons, focusing on the twin-pore K + channels TREK-1 and TASK-1 that set resting membrane potential and regulate excitability. Pharmacological inhibition of TREK-1 significantly increased spike frequency in Short and Equinox photoperiods, but did not further elevate the firing rate in slices from Long photoperiod mice, suggesting that TREK-1 function is reduced in Long photoperiods. In contrast, inhibition of TASK-1 resulted in increases in firing rates across all photoperiods, suggesting that it contributes to setting excitability, but is not regulated by photoperiod. We then quantified Kcnk2 mRNA levels specifically in dorsal raphe 5-HT neurons using triple-label RNAscope. We found that Long photoperiod significantly reduced levels of Kcnk2 in serotonin neurons co-expressing Tph2, and Pet-1. Photoperiodic effects on the function and expression of TREK-1 were blocked in melatonin 1 receptor knockout (MT-1KO) mice, consistent with previous findings that MT-1 signaling is necessary for photoperiodic programming of dorsal raphe 5-HT neurons. Taken together these results indicate that photoperiodic regulation of TREK-1 expression and function plays a key role in photoperiodic programming the excitability of dorsal raphe 5-HT neurons.
Keywords: electrophysiology, melatonin signaling, MT-1, photoperiod, serotonin, TREK-1
1 |. INTRODUCTION
External environment signals can have significant impact on the development of brain and behavior. Early-life experiences have enduring effects on neural development, which in turn impact behavioral phenotypes in adulthood.1–4 Day length (photoperiod) is a pervasive environmental signal that has been shown to program function of serotonergic function and behaviors in rodents3,5,6 and recently has been shown to associate with the life-time risk of major depression in humans.7 Nevertheless, the neural and molecular correlates underlying this complex relationship remain to be found.
Perinatal photoperiod has been linked to enduring changes in the circadian clock expression in the suprachiasmatic nucleus (SCN), the central pacemaker of circadian activity.8 Our laboratory has shown that mice raised until weaning in long (summer-like) photoperiods exhibited less depressive- and anxiety-like behaviors as adults than mice raised in short (winter-like) conditions.5 At the neural level, 5-HT neurons from Long mice showed increased excitability—depolarization of the resting membrane potential and a decrease in the amplitude of the afterhyperpolarization (AHP), both of which may contribute the increased spike frequency generated by a given amount of injected depolarizing current. Furthermore, these behavioral and neural changes elicited by developmental photoperiod were negated in melatonin receptor 1 (MT-1) knockout mice, indicating that melatonin signaling is required for the changes induced by photoperiod to DRN serotonin neurons. Although it is clear that developmental photoperiod programs 5-HT neurons, the specific molecules and processes that are targeted remain to be elucidated.
Resting membrane potential in many neurons is maintained by twin-pore K + channels. These channels shape the excitability of neurons by setting the resting membrane potential and by opposing depolarizing inputs.9 In the mouse DRNs, the most highly expressed isoforms of these channels are TREK-1 and TASK-1.10 Given the changes induces by developmental photoperiod both at the behavioral and neural levels, examining the response of these channels in mice to photoperiod may provide insight into the mechanisms of photoperiodic programming of 5-HT DRN neurons.
TREK-1 is of particular interest since the removal of the channel via constitutive knockout results in an anti-depressive-like phenotype.11 TREK-1 is known to be regulated by the induction of cAMP fluctuations thru Gs- or Gi-coupled receptors and activation of Gq protein pathways (12 Haiyan.13 In vivo extracellular recordings of DRN 5-HT neurons revealed that a significant increase in the firing rate of neurons of TREK-1 KO compared to wild type mice.11 These findings suggest TREK-1 channel as a novel candidate target for the treatment of depression.14
TREK-1 channels are mostly insensitive to antagonists of voltage-gated K+ channels such as tetraethylammonium (TEA) and 4-aminopyridine (4-AP),15 and however, recent work has shown the successful inhibition of TREK-1 using amlodipine, a dihydropyridine originally used Ca2 + channel antagonist.16 The IC50 of amlodipine for TREK-1 inhibition (430 nM) is 100-fold less than the required dose for inhibition of Ca2 + channels, making one of the first specific antagonists to the channel.17–19 More recent work has shown that spadin, a peptide derived from the maturation of the neurotensin receptor 3, specifically binds to TREK-1, blocking channel activity in vitro and increases the firing rate of 5-HT neurons of the raphe in vivo.20 Also, in behavioral tests spadin-treated mice presented depression-resistant phenotypes, similar to TREK-1 KO.
The goal of this study was to determine the potential roles of TREK-1 and TASK-1 in the ionic mechanisms that alter the spike rate of dorsal raphe 5-HT neurons in mice raised in different photoperiods. We hypothesized that photoperiod increased excitability of 5-HT neurons could result from a reduction in TREK-1 and/or TASK-1 activity. Furthermore, potential changes to the response of pharmacological inhibition could be the result of changes in the gene expression profile of the channel. To test these hypotheses, we performed multielectrode array recordings on Long, Equinox and Short photoperiod mice where we inhibited either TREK-1 and TASK-1 channels. In addition, we examined the mRNA expression levels of K nck-2 (TREK-1) in 5-HT neurons using quantitative in situ hybridization technique RNAscope.
2 |. METHODS
2.1 |. Animals and housing
C3Hf+/+ males and females were developed and raised to maturity on either Equinox (12 hours of light 12 hours of darkness), Short (8 hours of light and 16 hours of darkness), or Long (16 hours of light and 8 hours of darkness) photoperiods. Experimental assays were performed between ages P40 to P60 with tissues isolated at 11:00 am-12:00 pm local time, the midday point on all light cycles. Male and female animals were used in equal numbers in each cohort. MT-1 receptor knockout mice in the C3Hf+/+ background were bred and raised under the same conditions as the C3Hf+/+ mice. Genotype was confirmed before breeding the animals and before each experiment. Experiments were performed in accordance with the Vanderbilt University Institutional Animal Care and Use Committee and National Institutes of Health guidelines.
2.2 |. Multielectrode array electrophysiological recording
Mice were euthanized, brains were extracted and mounted in cold, oxygenated (95%O2-5%CO2) dissecting media (in mM: 114.5 NaCl, 3.5 KCL, 1 NaH2PO4, 1.3 MgSO4, 2.5 CaCl, 10 D(+)-glucose, and 35.7 NaCHO3), and 300-μm thick coronal slices were taken using a Leica V2100 (Leica Instruments). Dorsal raphe nuclei were isolated by removing the extraneous cortical tissue and placed sample in a slice chamber full of room temperature, oxygenated, extracellular recording media (in mM: 124 NaCl, 3.5 KCl, 1 NaH2PO4, 1.3 MgSO4, 2.5 CaCl2, 10 D(+)-glucose, and 20 NaHCO3). Multielectrode array recordings were performed by dissecting out the dorsal raphe nucleus after slicing. The tissue was placed on a perforated electrode array and immobilized with a harp for recording. To elicit spontaneous firing of serotonin neurons, 40 μM tryptophan and 3 μM phenylephrine were added to the recording solution which was perfused (1.3 mL/s) over the slice. After 45 minutes of placing, the slice in solution recording began. For TREK-1, inhibition amlodipine was perfused (1.3 mL/s) over the slice in a serial manner at concentrations of 0, 500 nM, 5 μM, and 10 μM. Each dose was perfused for 5-min to ensure the desired concentration in the bath. For spadin, the same protocol was used with the following dosages 0, 70 nM, 700 nM, and 7 μM. Inhibition of TASK-1 was achieved using highly specific inhibitor ML-365 at 0, 20 nM, 200 nM, and 400 nM.21 Lastly, 8-OH DPAT was perfused into the solution at 5 μM concentration to silence serotonergic cells.
2.3 |. RNAscope quantification
Mouse (n = 6 per group) whole brain tissue was collected and submerged into isopentane for 25 seconds, placed in crushed dry ice for approximately 1 minute, and stored in a 50-mL falcon tube at −80°C. 20-μm sections were prepared per animal targeting the dorsal raphe (DRN) from −5.5 mm to −5.75 mm from Bregma. Tissue sections were then stained with RNAscope in situ hybridization, targeting the transcripts Kcnk2 (TREK-1), Tph2, and Pet-1 with fluorescent dyes Alexa488, Atto550, and Atto647, respectively. Once tissue was processed, laser scans for each fluorescent channel containing the dorsal raphe nucleus for each brain slice were captured using a Zeiss LSM510 confocal scanning microscope (Carl Zeiss Microscopy Gmbh). Sixteen sequential scans at 40× of 512 × 512 pixels were taken by the microscope and stitched together to produce a high-resolution composite of the area. Laser settings and pinhole sizes were the same for all the captures. Image analysis was performed using the open source software Fiji (https://imagej.net/Fiji). Colocalization of Kcnk2 with Tph2 and Pet-1 was established using the plugin ComDet.22 Briefly, the plugin determines small ROIs each channel independently and determines whether they colocalize spatially with up to 4 pixels of distance from each other. Number of colocalized particles is reported as a proxy for gene expression levels.
2.4 |. Statistical analysis
Traces were analyzed using offline sorting (Plexon), and spikes were sorted using a combination of manual identification and automatic K means scan based sorting software. Graphs and statistics were prepared using GraphPad PRISM 8. Repeated measures two-way ANOVA was performed for each of the cohorts using photoperiod and inhibitor dose as independent variables. Since we used male and female mice in each of the cohorts in equal numbers, sex differences were analyzed for all cohorts. No significant differences were observed in either C3Hf+/+ or MT-1KO cohorts.
3 |. RESULTS
3.1 |. Photoperiod alters DRN 5-HT Neuron Spike Rate through TREK-1 but not TASK-1
To determine whether photoperiod programs TREK-1 or TASK-1 in DRN serotonin neurons, we performed multielectrode array recordings on acute brain slices containing the dorsomedial region of the DRN of mice (C3Hf+/+) conceived and raised in either Long (summer-like), Equinox (spring/fall like), or Short (winter-like) photoperiods and tested for dose-response effects of specific pharmacological inhibitors on spike rate. Serotonin neurons were identified by suppression of spiking in response to 8-OHDPAT at the end of each recording. Data were analyzed by repeated measures two-way ANOVA for main effects on spike rate of photoperiod, inhibitor dose, and an interaction of photoperiod with inhibitor dose. We hypothesized that if one of these K + channels contributes to by photoperiodic programming of excitability, then this would be revealed by a significant interaction between photoperiod and inhibitor dose on spike rate.
TREK-1 channels were pharmacologically inhibited using the dihydropyridine amlodipine besylate (0–10 μM, IC50 = 430 nM) which has been shown to be a potent inhibitor of TREK-1 channels at concentrations where it has minimal antagonism of Ca2 + channels.16 We hypothesized that photoperiod increased excitability of 5-HT neurons might result from a reduction in TREK-1 activity, and thus, 5-HT neurons from Long photoperiod mice would be unresponsive to pharmacological inhibition of TREK-1. Consistent with this hypothesis, the firing rate of 5-HT neurons from the Long cohort was not increased by amlodipine besylate, even at doses well-above the IC50, while that of neurons originating from Equinox and Short photoperiod mice increased in a dose-dependent manner (Figure 1A). Repeated measures two-way ANOVA analysis revealed a significant interaction between photoperiod and amlodipine dose (P < .001***) and main effects of amlodipine dose alone (P < .0001****). At the higher doses amlodipine may have partially inhibited Ca2 + currents, so we used a second specific TREK-1 inhibitor spadin (0–7 μM, IC50 = 70.7 nM) to further test our hypothesis. Results with spadin were similar to amlodipine, with no further effect of spadin inhibition of TREK-1 on the already elevated spike rate of neurons of Long photoperiod mice (Figure 1B). Overall the RM two-way ANOVA analysis revealed a significant interaction between photoperiod and spadin dose (P < .001***). As with amlodipine, we also observed a significant increase in the spike rate of the Equinox cohort, but the increase in firing rate in the Short cohort with spadin did not reach statistical significance. These results suggest that photoperiod programs TREK-1 channel function in dorsal raphe 5-HT neurons.
In addition to TREK-1, the TASK-1 channel is also highly expressed in the DRN and shares the role of maintaining the resting membrane potential. Using a highly specific TASK-1 inhibitor ML-365 (0–10 μM, IC50 = 4 nM,21), we tested if photoperiodic programming altered TASK-1 function in serotonin neurons of the DRN. TASK-1 inhibition resulted in a significant increase in firing rate in the three photoperiod cohorts (Figure 2). Statistical analysis via two-way RM ANOVA revealed significant effects of Ml-365 dose (P < .0001****) and photoperiod (P = .004**), but no significant interaction (P = .68). These data suggest that while TASK-1 can regulate the excitability in DRN serotonin neurons, it does not contribute to photoperiodic programming.
3.2 |. Long photoperiod decreases the expression TREK-1 mRNA in serotonin neurons
To determine whether the decrease in measurable TREK-1 inhibition in Long photoperiod was the result of changes at the gene expression level, we employed RNAscope to determine the abundance of Kcnk2 exclusively in Tph2 and Pet-1-positive neurons of the DRN (Figure 3). The resulting analysis revealed significant differences in the levels of Kcnk2 (TREK-1) transcripts colocalized with Tph2 and Pet-1 (one-way ANOVA, F = 4.991, P = .0218). Specifically, 5-HT neurons of Long photoperiod mice had significantly lower levels of Kcnk2 transcripts, compared to Short photoperiod mice (Figure 3).
3.3 |. Photoperiod programming of TREK-1 requires melatonin signaling
Photoperiodic programming of the excitability of DRN serotonin neurons requires melatonin signaling through the MT-1 melatonin receptor.5 Given our results suggesting that TREK-1 is a target of this programming, we hypothesized that in the absence of a functional melatonin pathway, TREK-1 would not be regulated across photoperiods. We tested this using spike rate assays of amlodipine inhibition of TREK-1 in DRN slices, and RNAscope of TREK-1 expression in DRN serotonin neurons. In contrast to the above results for mice with intact melatonin signaling (Figure 1), in MT-1 knockout mice TREK-1 inhibition by amlodipine had no significant effect on the firing rate of DRN serotonin neurons in any photoperiod, and there was no interaction between photoperiod and amlodipine (Figure 4A). Furthermore, in MT-1 knockout mice DRN serotonin neuron Kcnk2 transcript expression was similar across all photoperiods (Figure 4B), again in contrast to the observed decrease in Kcnk2 in Long photoperiod melatonin signaling-competent mice (Figure 3). These results suggest that photoperiod acts on TREK-1 expression and function through MT-1 melatonin signaling to program DRN serotonin neuron excitability.
4 |. DISCUSSION
Our findings demonstrate that photoperiod differently alters the function and expression of the key resting membrane potential regulator TREK-1 in adult 5-HT neurons, but not TASK-1. Results with TREK-1 blockers amlodipine and spadin suggest that reduced TREK-1 function following exposure to Long photoperiods is a key element in the photoperiod-driven increase in 5-HT neuron spike rate and excitability, and quantification of Kcnk2 transcript levels by RNAscope demonstrated directly that TREK-1 expression is reduced in DRN serotonergic neurons in Long photoperiods. Finally, we tested the necessity of melatonin MT-1 signaling for photoperiod programming of TREK-1, and found that, like programming of overall DRN serotonin neuron excitability, the programming of TREK-1 function and expression is dependent on melatonin signaling. Taken together, our findings suggest that photoperiod acts at the transcriptional level on TREK-1, potentially influencing the number of active TREK-1 channels on 5-HT neurons, which then contributes to the previously observed differences in excitability of these neurons as well as anxiety-like and depressive-like phenotypes following development in different photoperiods.
Research examining TREK-1’s association with depression-like behaviors has shown that deletion of the sorting protein NTSR3/Sortilin (Sort1−/−) results in depression-resistant phenotypes, increased activity of DRN neurons, and a decrease in cell surface levels of TREK-1. Sort1−/− mice present similar phenotypes and electrophysiological properties of 5-HT neurons to TREK-1 knockout mice and Long photoperiod mice.5,11,23 Thus, the lack of significant increase in firing rate in Long photoperiod mice upon TREK-1 inhibition suggests low levels of functional TREK-1 channels in 5-HT neurons. Furthermore, spadin, which we used to inhibit TREK-1, when administrated to mice via intraperitoneal injections elicits an increase in the firing rate of 5-HT neurons in vivo and a decrease in depression-like behaviors.20,24 Thus, our results provide strong support for programming of TREK-1 channels as a key driver of the behavioral effects of developmental photoperiod.
Our finding that Kcnk2 levels in 5-HT neurons are significantly decreased in Long photoperiod mice provides a potential mechanism by which photoperiod modulates TREK-1 channels, but it does not preclude other potential avenues. For example, it is possible that photoperiod may also be acting on NTSR3/Sortilin, which would affect the trafficking of TREK-1 to the membrane. This is a possible scenario in the context of our Short photoperiod results where we observed small increases in firing rate in response to spadin, but Kcnk2 transcript levels are high in 5-HT neurons (Figures 1 and 3).
Consistent with previous results showing that melatonin signaling is required for photoperiodic programming of 5-HT neurons in the raphe,5 our results here show that MT-1 knockout mice are irresponsive to photoperiod and that MT-1 knockouts are unresponsive to pharmacological inhibition of TREK-1 (Figure 4). Thus, it is possible that the lack of melatonin signaling in these mice keeps the 5-HT system from adjusting to photoperiod. In C57BL/6 mice, TREK-1 is expressed in different regions of the brain as early as E15, and expression levels assayed thru in situ hybridization and qPCR remain stable thru adulthood.25 Since C57BL/6 mice are not melatonin competent, it would be interesting to examine the levels of TREK-1 expression across different photoperiods in melatonin competent mice (eg, C3Hf+/+) throughout embryonic development.
Recent work examining the distribution and expression of MT-1 the mouse brain using reporter genes revealed that within the DRN MT-1 is expressed at very low levels with isolated, scattered, lightly labeled neurons within the DRN.26 Furthermore, single-cell transcriptomics analysis of Pet-1-positive DRN neurons did not reveal significant expression of MT-1 receptors.27 Therefore, it is highly likely that MT-1 receptor signaling in other brain regions is driving the observed photoperiodic effects.
Given that MT-1 is minimally expressed in the mouse DRN, one question that remains a subject of future work is how melatonin signaling, via the MT-1 receptor, may regulate TREK-1 mRNA expression levels. One possible hypothesis we propose is that melatonin signaling thru the suprachiasmatic nuclei (SCN) may regulate TREK-1 mRNA levels in the DRN. This is consistent with the findings of this paper since MT-1 is highly expressed in the mouse SCN,26 photoperiodic information is received directly by the SCN via the retinohypothalamic tract, and the SCN makes polysynaptic output to the DRN.28
The work presented here shows that an external environmental cue, day length, programs a critical component of the neuronal machinery of serotonin neurons at the transcriptional level, thus causing changes of the electrophysiological properties of these neurons, which can lead to enduring changes in depression and anxiety behaviors. Understanding the mechanisms of TREK-1 channel modulation in relation to serotonergic function and behavior may lead to new treatments for mood disorders. Our future efforts will concentrate on dissecting how developmental photoperiod via melatonin signaling pathways regulates TREK-1.
ACKNOWLEDGEMENTS
This research was supported by National Institutes of Health Grants NIH R01 MH108562 to DGM and the Postdoctoral program in Functional Neurogenomics grant 5T32MH065215-13. The authors would like to thank, Turnee Malik, Michael Tackenberg, David Sprinzen, and the Vanderbilt Vision Research Center for their advice and support.
Footnotes
CONFLICT OF INTEREST
The authors declare no conflicts of interest.
DATA AVAILABILITY STATEMENT
The data that support the findings of this study are available from the corresponding author upon reasonable request.
REFERENCES
- 1.Andersen SL. Exposure to early adversity: points of cross-species translation that can lead to improved understanding of depression. Dev Psychopathol. 2015;27(2):477–491. 10.1017/S0954579415000103 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Boulle F, Pawluski JL, Homberg JR, et al. Prenatal stress and early-life exposure to fluoxetine have enduring effects on anxiety and hippocampal BDNF gene expression in adult male offspring. Dev Psychobiol. 2016;58(4):427–438. 10.1002/dev.21385 [DOI] [PubMed] [Google Scholar]
- 3.Pyter LM, Nelson RJ. Enduring effects of photoperiod on affective behaviors in Siberian hamsters (Phodopus sungorus). Behav Neurosci. 2006;120(1):125–134. 10.1037/0735-7044.120.1.125 [DOI] [PubMed] [Google Scholar]
- 4.Rincón-Cortés M, Sullivan RM. Early life trauma and attachment: Immediate and enduring effects on neurobehavioral and stress axis development. Front Endocrinol. 2014;5:1–15. 10.3389/fendo.2014.00033 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Green NH, Jackson CR, Iwamoto H, Tackenberg MC, McMahon DG. Photoperiod programs dorsal raphe serotonergic neurons and affective behaviors. Curr Biol. 2015;25(10):1389–1394. 10.1016/j.cub.2015.03.050 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Siemann JK, Green NH, Reddy N, McMahon DG. Sequential photoperiodic programing of serotonin neurons, signaling and behaviors during prenatal and postnatal development. Front Neurosci. 2019;13:1–13. 10.3389/fnins.2019.00459 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Devore EE, Chang SC, Okereke OI, McMahon DG, Schernhammer ES. Photoperiod during maternal pregnancy and lifetime depression in offspring. J Psychiatr Res. 2018;104:169–175. 10.1016/j.jpsychires.2018.08.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Ciarleglio CM, Axley JC, Strauss BR, Gamble KL, McMahon DG. Perinatal photoperiod imprints the circadian clock. Nat Neurosci. 2011;14(1):25–27. 10.1038/nn.2699 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Talley EM, Solórzano G, Lei Q, Kim D, Bayliss DA. CNS distribution of members of the two-pore-domain (KCNK) potassium channel family. J Neurosci. 2001;21(19):7491–7505. 10.1523/JNEUROSCI.21-19-07491.2001 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Medhurst AD, Rennie G, Chapman CG, et al. Distribution analysis of human two pore domain potassium channels in tissues of the central nervous system and periphery. Mol Brain Res. 2001;86(1–2):101–114. 10.1016/S0169-328X(00)00263-1 [DOI] [PubMed] [Google Scholar]
- 11.Heurteaux C, Lucas G, Guy N, et al. Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype. Nat Neurosci. 2006;9(9):1134–1141. 10.1038/nn1749 [DOI] [PubMed] [Google Scholar]
- 12.Enyeart JA, Liu H, Enyeart JJ. cAMP analogs and their metabolites enhance TREK-1 mRNA and K+ current expression in adrenocortical cells. Mol Pharmacol. 2010;77(3):469–482. 10.1124/mol.109.061861 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Liu H, Enyeart JA, Enyeart JJ. ACTH inhibits bTREK-1 K+ channels through multiple cAMP-dependent signaling pathways. J General Physiol. 2008;132(2):279–294. 10.1085/jgp.200810003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Borsotto M, Veyssiere J, Maati MOH, Devader C, Mazella J, Heurteaux C. Targeting two-pore domain K+ channels TREK-1 and TASK-3 for the treatment of depression: a new therapeutic concept. Br J Pharmacol. 2015;172(3):771–784. 10.1111/bph.12953 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Gomora JC, Enyeart JJ. Dual pharmacological properties of a cyclic AMP-sensitive potassium channel. J Pharmacol Exp Ther. 1999;290(1):266–275. [PubMed] [Google Scholar]
- 16.Liu H, Enyeart JA, Enyeart JJ. Potent inhibition of native TREK-1 K+ channels by selected dihydropyridine Ca2+ channel antagonists. J Pharmacol Exp Ther. 2007;323(1):39–48. 10.1124/jpet.107.125245 [DOI] [PubMed] [Google Scholar]
- 17.Enyeart JJ, Mlinar B, Enyeart JA. T-type Ca2+ channels are required for adrenocorticotropin-stimulated cortisol production by bovine adrenal zona fasciculata cells. Mol Endocrinol. 1993;7(8):1031–1040. 10.1210/me.7.8.1031 [DOI] [PubMed] [Google Scholar]
- 18.Heady TN, Gomora JC, Macdonald TL, Perez-Reyes E. Molecular pharmacology of T-type Ca2+ channels. Jpn J Pharmacol. 2001;85(4):339–350. 10.1254/jjp.85.339 [DOI] [PubMed] [Google Scholar]
- 19.Santi CM, Cayabyab FS, Sutton KG, et al. Differential inhibition of T-type calcium channels by neuroleptics. J Neurosci. 2002;22(2):396–403. 10.1523/jneurosci.22-02-00396.2002 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Mazella J, Pétrault O, Lucas G, et al. Spadin, a Sortilin-Derived peptide, targeting rodent TREK-1 channels: a new concept in the antidepressant drug design. PLoS Biol. 2010;8(4):e1000355. 10.1371/journal.pbio.1000355 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Flaherty DP, Simpson DS, Miller M, et al. Potent and selective inhibitors of the TASK-1 potassium channel through chemical optimization of a bis-amide scaffold. Bioorg Med Chem Lett. 2014;24(16):3968–3973. 10.1016/j.bmcl.2014.06.032 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Fréal A, Rai D, Tas RP, et al. Feedback-driven assembly of the axon initial segment. Neuron. 2019;104(2):305–321.e8. 10.1016/j.neuron.2019.07.029 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Moreno S, Devader CM, Pietri M, Borsotto M, Heurteaux C, Mazella J. Altered TREK-1 function in sortilin deficient mice results in decreased depressive-like behavior. Front Pharmacol. 2018;9:1–13. 10.3389/fphar.2018.00863 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Djillani A, Pietri M, Moreno S, Heurteaux C, Mazella J, Borsotto M. Shortened spadin analogs display better TREK-1 inhibition, in vivo stability and antidepressant activity. Front Pharmacol. 2017;8:e00643. 10.3389/fphar.2017.00643 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Aller MI, Wisden W. Changes in expression of some two-pore domain potassium channel genes (KCNK) in selected brain regions of developing mice. Neuroscience. 2008;151(4):1154–1172. 10.1016/j.neuroscience.2007.12.011 [DOI] [PubMed] [Google Scholar]
- 26.Klosen P, Lapmanee S, Schuster C, et al. MT1 and MT2 melatonin receptors are expressed in nonoverlapping neuronal populations. J Pineal Res. 2019;67(1):1–19. 10.1111/jpi.12575 [DOI] [PubMed] [Google Scholar]
- 27.Okaty BW, Sturrock N, Lozoya YE, et al. A single-cell transcriptomic and anatomic atlas of mouse dorsal raphe Pet1 neurons. ELife. 2020;9:1–44. 10.7554/eLife.55523 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Deurveilher S, Semba K. Indirect projections from the suprachiasmatic nucleus to major arousal-promoting cell groups in rat: Implications for the circadian control of behavioural state. Neuroscience. 2005;130(1):165–183. 10.1016/j.neuroscience.2004.08.030 [DOI] [PubMed] [Google Scholar]